Showing results (291-300 of 6,764) with videos related to

Sort By:
Pageof 677
European Journal of Gastroenterology & Hepatology|May 13, 2025
The role of chest X-ray in detecting latent tuberculosis among patients with low-risk inflammatory bowel disease before advanced therapyYvette Gatt, Daniela Chatlani, Clive Camilleri, et al.
European Journal of Gastroenterology & Hepatology|May 13, 2025
Lens culinaris-agglutinin-reactive fraction of alpha-fetoprotein is a prognostic biomarker in atezolizumab plus bevacizumab for hepatocellular carcinomaJumpei Okamura, Hideyuki Tamai
European Journal of Gastroenterology & Hepatology|May 13, 2025
The safety and efficacy of rituximab in autoimmune hepatitis: a systematic review and quality assessmentMohammad Amin Habibi, Fatemeh Aghayee, Mohammad Sina Mirjani, et al.
European Journal of Gastroenterology & Hepatology|January 28, 2026
Comparative assessment of model for end-stage liver disease, modified model for end-stage liver disease including sodium, and Maddrey's discriminant function in alcoholic hepatitis mortality: a systematic review and diagnostic meta-analysisJúlia Mendes Tschaen, Matheus Vanzin Fernandes, Erica Uchoa Holanda, et al.
European Journal of Gastroenterology & Hepatology|January 28, 2026
Cardiovascular outcomes and subclinical atherosclerosis in metabolic-associated steatotic liver disease: long-term follow-up from a specialized outpatient cohortPedro Miguel M Nogueira, Carlos Eduardo C Marques, Breno C Vieira, et al.
European Journal of Gastroenterology & Hepatology|January 28, 2026
Clinical course and prognostic risk factors of SARS-CoV-2 vaccine-related hepatitis: differentiating severe acute respiratory syndrome coronavirus 2 vaccine-associated liver injury from autoimmune hepatitisDonald Malino, Greta Codoni, Theresa Kirchner, et al.
European Journal of Gastroenterology & Hepatology|January 28, 2026
Safety evaluation of drug-eluting bead transarterial chemoembolization in combination with immune checkpoint inhibitors in the treatment of unresectable intrahepatic cholangiocarcinoma: risk factors for liver abscessLonghao Bian, Lihua Luo, Guoquan Kang, et al.
European Journal of Gastroenterology & Hepatology|January 28, 2026
Risk factors for hepatic failure after transarterial chemoembolization in patients with hepatocellular carcinoma: a systematic review and meta-analysisVitchapong Prasitsumrit, Ben Thiravetyan, Tulaton Sodsri, et al.
European Journal of Gastroenterology & Hepatology|October 16, 2003
High-grade dysplasia in sporadic fundic gland polyps: clinically relevant or not?Manfred Stolte, Michael Vieth, Matthias P Ebert
European Journal of Gastroenterology & Hepatology|October 16, 2003
Detection of identical Helicobacter DNA in the stomach and in the non-cirrhotic liver of patients with hepatocellular carcinomaCornelis Verhoef, Raymond G Pot, Rob A de Man, et al.
Pageof 677